Publication | Closed Access
Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma
303
Citations
28
References
2014
Year
GPC3-targeted CAR T cells could potently eliminate GPC3-positive HCC cells, thereby providing a promising therapeutic intervention for GPC3-positive HCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1